Home > Boards > US Listed > Biotechs > MediciNova, Inc. (MNOV)

I don't mind buying on the way up

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Ebuilder Member Profile
 
Followed By 10
Posts 1,206
Boards Moderated 0
Alias Born 11/22/13
160x600 placeholder
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 3/16/2020 7:18:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/13/2020 5:53:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/12/2020 6:40:08 PM
MediciNova Announces Plans to Develop MN-166 (ibudilast) for Severe Pneumonia and Acute Respiratory Distress Syndrome (ARDS) GlobeNewswire Inc. - 3/9/2020 7:00:10 PM
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Advanced NASH in Japan... GlobeNewswire Inc. - 2/17/2020 6:00:10 PM
Annual Report (10-k) Edgar (US Regulatory) - 2/13/2020 4:25:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2020 12:22:11 PM
MediciNova Receives Notice of Intention to Grant for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fib... GlobeNewswire Inc. - 1/27/2020 6:00:10 PM
MediciNova Announces Additional Analyses from Completed Clinical Trial of MN-166 (ibudilast) in ALS Presented at the 30th Int... GlobeNewswire Inc. - 12/4/2019 6:00:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/28/2019 6:11:04 AM
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Amyotrophic Lateral S... GlobeNewswire Inc. - 10/28/2019 6:00:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/25/2019 6:10:22 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/25/2019 6:10:04 AM
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of NAFLD and NASH in Japan GlobeNewswire Inc. - 10/23/2019 6:00:05 AM
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Idiopathic Pulmonary F... GlobeNewswire Inc. - 10/7/2019 7:00:00 PM
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in ... GlobeNewswire Inc. - 9/30/2019 7:00:00 PM
MediciNova to Present at the Ladenburg Thalmann 2019 Healthcare Conference in New York GlobeNewswire Inc. - 9/11/2019 7:00:00 PM
MediciNova to Attend the Morgan Stanley Global Healthcare Conference in New York GlobeNewswire Inc. - 8/29/2019 7:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2019 5:03:44 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/23/2019 5:02:32 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/23/2019 6:00:54 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/9/2019 5:03:28 PM
MediciNova Announces MN-001 Research Collaboration with the National Cerebral and Cardiovascular Disease Research Center in J... GlobeNewswire Inc. - 7/30/2019 7:00:00 PM
MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 30th International Symposium on ALS/MND... GlobeNewswire Inc. - 7/29/2019 7:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/26/2019 6:05:48 AM
Ebuilder   Thursday, 09/10/15 10:13:11 AM
Re: someconcerns post# 368
Post # of 392 
I don't mind buying on the way up for legit prospects like MNOV. I'll get more when I can smile

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist